Six-Month Clinical Data Demonstrate Restoration of Cone-Mediated Vision in Pediatric LCA5 Patients, with Sensitivity Improvements Reaching Normal ...

Sharon Fekrat MD, FACS, FASRS, discusses the future of retinal scans as a screening and risk stratification tool in neurology ...

New preclinical data presented demonstrate the candidates’ therapeutic potential as innovative treatments for retinal vascular diseases, such as DME and wAMD, providing potent and long-lasting ...

Prevent Blindness, the nation's leading patient advocacy organization dedicated to protecting and preserving eye health, has ...

Despite challenges for approval and access, regenerative therapies for retinal diseases may not be far away from becoming ...

Three 2026 Breakthrough Prize winners reflect on developing Luxturna, a gene therapy that treats blindness caused by rare ...

The Korea Research Institute of Standards and Science (KRISS) has developed a retina-mimicking eye phantom that faithfully replicates the structural layers and microvascular network of the human ...

Population-based studies have shown retinal disorders are the most common cause of irreversible blindness in developed countries and the second most common cause of blindness after cataracts in ...

Belite Bio, Inc. (NASDAQ: BLTE), (“Belite Bio” or the “Company”), a clinical-stage biopharmaceutical drug development company ...

Discusses BGE-102 Clinical Results and Development Strategy for Cardiovascular and Retinal Disease May 8, 2026 12:30 PM ...